The total number of outstanding shares will decrease by 37,856,768 shares due to the share consolidation, effective date April 28, 2026. Delisting scheduled for April 24, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3902","jir_company_name":"Medical Data Vision Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-03-24","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/3902-20260324-01.pdf","jir_short_summary":"The total number of outstanding shares will decrease by 37,856,768 shares due to the share consolidation, effective date April 28, 2026. Delisting scheduled for April 24, 2026.","jir_summary":"### Overview of Capital Policy\nMedical Data Vision Co., Ltd. approved at an extraordinary general meeting of shareholders held on March 24, 2026, the consolidation of common stock (consolidating 7,253,607 shares into 2 shares), abolition of the unit share system, and partial amendment to the articles of incorporation. As a result, the total number of outstanding shares will decrease by 37,856,768 shares, with the effective date set for April 28, 2026. Additionally, following the share consolidation, the company's shares are scheduled to be delisted from the Tokyo Stock Exchange Prime Market on April 24, 2026.\n\n### Impact on Shareholders and Future Schedule\nIn connection with the share consolidation, fractional shares less than one share will be sold, and the proceeds will be distributed to shareholders. The sale price per share is expected to be 1,693 yen, and Nippon Life Insurance Company is anticipated to purchase these shares. The procedures to sell fractional shares will involve filing for court approval in mid-May 2026, purchasing in mid-June, and delivering proceeds to shareholders by mid-August. Consequently, ultimately only the tender offeror and SBI Holdings will remain as shareholders.","jir_financial_highlights":"Consolidation Ratio: 7,253,607 shares consolidated into 2 shares (Unknown)\nDecrease in Total Number of Outstanding Shares: 37,856,768 shares (Unknown)\nTotal Number of Outstanding Shares After Effectiveness: 10 shares (Unknown)\nScheduled Delisting Date: 2026-04-24 (Unknown)","jir_category":"","jir_hashtags":"#MedicalDataVisionCoLtd, #CapitalPolicy, #ShareConsolidation, #Delisting","jir_key_figures":"Consolidation Ratio: 7,253,607 shares consolidated into 2 shares\nDecrease in Total Number of Outstanding Shares: 37,856,768 shares\nTotal Number of Outstanding Shares After Effectiveness: 10 shares","jir_meta_title":"Medical Data Vision Co., Ltd. to Reduce Outstanding Shares by 37,856,768 through Share Consolidation, Scheduled Delisting on April 24, 2026","jir_meta_description":"Medical Data Vision Co., Ltd. approved share consolidation and amendments to the articles of incorporation on March 24, 2026. The total number of outstanding shares will decrease by 37,856,768, with delisting from the Tokyo Stock Exchange Prime Market scheduled for April 24, 2026.","jir_og_title":"Medical Data Vision Announces Share Consolidation and Scheduled Delisting","jir_og_description":"Due to the share consolidation, the total outstanding shares will significantly decrease with delisting planned for April 24, 2026. Proceeds from the sale of fractional shares will be paid to shareholders at 1,693 yen per share.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17052,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-36104","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n